RESPIRONICS STOCK UP 7.9% IN MARCH AS INVESTORS BREATHE EASIER ABOUT LOSS OF APRIA CONTRACT; O-T-C INDEX HAS NO SPRING IN STEP, FALLS 9.3% IN MARCH
This article was originally published in The Gray Sheet
Executive Summary
Respironics stock edged out a 7.9% gain during March, a month in which poor performances by many O-T-C stocks left investors feeling winded.